Textbook theory holds that blood pressure (BP) is regulated by the brain, by blood vessels, or by the kidney. Recent evidence suggests that BP could be regulated in the skin.
INTRODUCTION
The most recent World Health Organization Global Burden of Disease survey has identified high blood pressure (BP) as the world's leading cause of premature death and disease, highlighting the importance of controlling hypertension [1] . However, the pathophysiological cause of essential hypertension is still unknown [2] . Hypertension research traditionally focuses on blood vessels, the brain, the heart, and the kidney. Extracellular volume control and blood flow is intimately coupled with long-term BP regulation. Skeletal muscle and skin are the body's major extracellular fluid compartments. The skin holds a complex capillary counter current system, which controls body temperature and skin perfusion. Emerging evidence suggests that local regulation of cutaneous blood flow and salt and water metabolism is relevant for systemic BP control. We review recent findings regarding the effects of sunlight exposure, hypoxia-inducible factors (HIF), and cutaneous sodium storage on skin vessel function and systemic BP levels.
Sunlight, skin vessel relaxation, and blood pressure
The process of photorelaxation was first described by Furchgott half a century ago. Isolated strips of arterial muscle relaxed on exposure to ultraviolet A (UVA) and visible light, consistent with photoreduction of stored nitrogen oxides [3] . The action spectrum of UV-induced release of nitric oxide from rat aorta matched that of low-molecular weight nitrosothiols and nitrite, suggesting that these might be the nitric oxide source [4] . Human skin has been shown to contain stores of nitrogen oxides around 10 times those present in the circulation [5] . Nitrate (NO 3 ) predominates, but nitrite (NO 2 ) and nitrosothiols are also present in significant quantities. Nitrate has until recently been considered a biologically inert end product of nitric oxide oxidation, but mammalian nitrate reduction can occur [6] , and in the presence of thiols ultraviolet radiation can reduce nitrate [7] . Irradiation of human volunteers with physiologically relevant fluences of UVA radiation produces a fall in BP, greater than that produced by skin heating to the same degree [8 && ,9] , and arterial vasodilatation independent of nitric oxide synthase. UVA does not cause vitamin D synthesis, but, contemporaneously with the fall in BP, circulating nitrite levels rose and nitrate levels fell [8 && ], suggesting that UV-induced nitric oxide mobilization from the skin to the systemic circulation accounts for sun-induced falls in BP. These physiological changes seem analogous to the photo-relaxation described by Furchgott.
Does sun exposure reduce cardiovascular risk and all-cause mortality?
Epidemiological data suggest that sunlight exposure plays a role in controlling BP. Seasonal variation in BP is well described in individuals living at temperate latitudes [1] and population BP correlates directly with latitude [10] . The synthesis of 1,25 di-hydroxy vitamin D requires irradiation of the skin with ultraviolet B wavelengths. Individuals with measured vitamin D levels in the upper quartile are around half as likely to have hypertension, myocardial infarction, or death from any cause as those in the lowest quartile. Meta-analyses of oral intervention studies show no benefit from supplementary vitamin D on BP [11] , heart disease, or stroke [12] however. Similarly, genetic determination of lifelong vitamin D levels by the carriage of alleles causing a reduction in synthesis of vitamin D, or substrate availability, is not associated with any increase in cardiovascular disease [13] . Vitamin D levels thus correlate inversely with BP and cardiovascular disease incidence, but are not causative. Vitamin D levels may reflect time spent outside undertaking exercise, which itself reduces BP, but a more parsimonious explanation, which accounts for geographic and Mendelian randomization data, is that sunlight exposure, independently of Vitamin D, is an effective hypotensive agent.
Dermatological concerns around sun exposure relate to the known carcinogenic effects of UV radiation, particularly on white skinned populations. Remarkably, there are no data showing an increase in all-cause mortality with increased sun exposure. Recently published high-quality prospective cohort studies from Scandinavia show a dose-dependent fall in all-cause mortality with increased sun exposure [14] , in particular cardiovascular mortality [15] . Nonmelanoma skin cancer can act as a marker for sun exposure. Case control analysis of the Danish population over the age of 40 shows that a diagnosis of nonmelanoma skin cancer is associated with a reduced odds ratio of all-cause mortality and a greater reduction of myocardial infarction [16] . In summary, experimental data suggest that sun exposure has a significant impact on nitric oxide-mediated blood flow in the systemic vasculature and thereby lowers BP. This BP-reducing effect of sunlight may reduce cardiovascular risk. The underestimated cardiovascular protection by sunlight may outnumber the well-known carcinogenic effects of UV radiation, and thereby reduce all-cause mortality.
Keratinocytes control blood flow, thermal adaptation, and systemic blood pressure levels
Keratinocytes and immune cells control blood flow in the extensive countercurrent loop system of the skin. Psoriasis is a keratinocyte-driven autoimmune disease with an increased risk of cardiovascular mortality [17] . Interleukin (IL) 17 is an important cytokine to drive auto-inflammation in psoriasis and plays a relevant pathophysiological role in experimental hypertension [18] . Karbach et al. [19] have recently studied the relationship between skin-derived autoinflammation and cardiovascular disease in an experimental psoriasis model with IL-17 overexpression in keratinocytes, and found severe arterial hypertension and premature cardiovascular death in the mice. Systemic inflammation with high systemic IL-17 levels occurred in the mice. The high and rapid cardiovascular mortality in this experimental model may therefore derive from direct proinflammatory effects in the systemic vasculature, heart, kidney, and brain; however, the underlying cause of the disease was keratinocytedriven autoimmune disease.
Cardiac output to the skin in humans can be as little as 1-2% in the cold, and as much as 60% in
KEY POINTS
The skin holds a complex capillary counter current system which controls body temperature, skin perfusion, and apparently systemic BP.
UVA irradiation modulates nitric oxide release and export from cutaneous stores and reduces BP, which could explain seasonal variation of BP.
Keratinocytes control skin blood flow via a balance between HIF 1a and HIF 2a.
Sodium is stored in the skin and its clearance through cutaneous lymph vessels is controlled by homeostatic immune cells, which thereby control systemic BP.
acute heat stress. Keratinocytes and many other tissues and cell types produce nitric oxide, a key regulator of vascular tone [20] , via nitric oxide synthase 2 (NOS2), in response to inflammatory stimuli as well as hypoxia. Nitric oxide production via NOS2 is in part under the control of the hypoxiainducible transcription factors, HIF-1a and HIF-2a. In macrophages, proinflammatory M1 polarization induces NOS 2 activity, which is in part promoted by HIF-1a, whereas HIF-2a helps to drive arginase activity via both the ARG1 and ARG2 loci, and supports alternative M2 polarization with generation of urea osmolyte from L-arginine [21] . Similarly, keratinocytes generate nitric oxide in a HIF-1a/NOS2-dependent manner, whereas HIF-2a promotes keratinocyte arginase expression [22 && ]. The balance between HIF-1a and HIF-2a activity in keratinocytes thereby controls skin perfusion, systemic thermoregulation, and systemic BP [22 && ]. Mice with a deletion of HIF-1a in keratinocytes show reduced blood vessel diameter, dissipate less thermal energy through the skin, show increased core temperature after exercise, and have elevated systemic BP. Conversely, deletion of HIF-2a activity in keratinocytes reduces arginase expression, and shifts the balance between nitric oxide versus urea production toward nitric oxide, resulting in increased skin nitric oxide levels, augmented body core temperature loss in the cold, and reduced systemic BP. These findings provide clear mechanistic insights into how systemic BP is regulated in the skin. This keratinocyte-driven nitric oxide homeostatic mechanism may also be a factor in the regulation of human arterial pressures; in patients with essential hypertension, increased BP levels are associated with reduced nitric oxide levels in the skin, which are paralleled by a reduction of cutaneous HIF-1a protein levels, while HIF-2a protein levels were increased [22 && ].
Sodium storage in the skin is associated with hypertension
Apart from the novel findings on the importance of skin perfusion and temperature regulation, studies also suggest that cutaneous electrolyte metabolism is coupled with systemic BP control. It is a welldocumented clinical observation that arterial hypertension occurs with age, and that women have lower BP than men. Quantitative magnetic resonance sodium imaging (23) studies have revealed that these characteristics of essential hypertension are closely associated with sodium storage in the skin. Humans increase skin sodium content as they age, and women have lower skin sodium content than men [23] . A recent study suggests that skin sodium storage, apart from its 'adverse' association with BP increase, may have an unexpected biological advantage in that it boosts host defense [24 && ]. Sodium accumulates at the site of skin infections and triggers proinflammatory activation of macrophages. This NOS2-dependent M1 polarization improves the cells' antimicrobial capacity. Local salt deposition apparently serves as an ancient mechanism to aid in immune-mediated pathogen removal. This ancient pattern might become activated with age when biological barrier function against microbial invaders declines, albeit at the price of arterial hypertension. Salt metabolism is thus not just a renal affair [25] [26] [27] , but instead a homeostatic process that is regulated locally at the tissue level in response to inflammatory stimuli. Similarly, highsalt conditions reduce the ability of noninflammatory macrophages to suppress CD8þ and CD4þ T cells [28] . Comparable salt-driven 'M(Na)' macrophage polarization is not restricted to the skin, but also found in lung macrophages [29] .
The pathophysiological mechanisms, by which sodium storage in the skin may elevate systemic BP, are currently unknown. One hypothesis is that salt storage induces a proinflammatory 'host defense-like' immune response, which leads to local reactive oxygen species generation with vasoconstriction and elevated BP [24 && ]. In line with this idea, cutaneous blood vessels show increased contractility when salt storage is induced in the skin [30] . An alternative approach toward the role of immune cell action in the salt-rich microenvironment of the skin is the concept that immune cells act as physiological regulators of local tissue sodium content by controlling a kidney-like functional vascular countercurrent/lymphatic clearance system hidden in the skin [31] .
Macrophages control lymphatic skin electrolyte clearance and blood pressure
Ultra-high-field 23 magnetic resonance sodium imaging studies with higher resolution have revealed that the age-dependent Na þ accumulation in humans takes place inside or directly under the skin keratinocyte layer [32] . Analysis of the microanatomy of cutaneous Na þ distribution suggests energy-dependent electrolyte concentration processes in the basal layer of the skin, with high salt concentrations in the dermal papillae directly under the keratinocyte layer [33] . It is unclear how these kidney-like electrolyte gradients are generated. Epithelial sodium channel activity in keratinocytes might play an important major role in the concentration process [34] . Arterioles ascend through the dermis and perfuse a capillary countercurrent loop system that extends upward into the dermal papillae just beneath the epidermis. Lymph vessels drain interstitial fluid from these blood vascular counter current loops. Similarly to the renal control of sodium excretion, this local cutaneous lymphatic clearance process is intimately coupled with systemic BP control. In rodents, skin macrophages exposed to high salt concentrations exert physiological-regulatory activity [35] , induce increased lymph capillary pumping [36, 37] , and improve lymphatic clearance of cutaneous sodium reservoirs by a vascular endothelial growth factor C-dependent mechanism. Blockade of this lymphatic clearance mechanism leads to sodium accumulation in the skin and BP increase [35, [38] [39] [40] . Clinical studies indicate that humans with age-dependent BP increase and skin sodium accumulation show reduced levels of prolymphangiogenic vascular endothelial growth factor C [41] . These findings suggest that local, tissue-specific control of skin electrolyte homeostasis is relevant for systemic BP control.
CONCLUSION
Systemic blood vessels dilate when skin nitric oxide levels are elevated. Keratinocytes elevate skin nitric oxide levels and lower BP when the skin is exposed to sunlight, and when HIF1-a levels are increased. Conversely, constriction of cutaneous blood vessels elevates systemic BP. Such increases in vascular contractility are triggered by keratinocytes by HIF 2-a/arginase-driven competition for L-arginine as a substrate for urea generation, by proinflammatory cytokine release from keratinocytes and skin immune cells, and by Na þ storage in the 'kidneylike' cutaneous vascular counter current system. BP regulation in humans and in experimental animals may thus be only skin deep.
